Medicare spending on breakthrough medications for hepatitis C will nearly double this year, passing $9 billion, according to new government figures. That's raising insurance costs for all beneficiaries, whether or not they have the liver-wasting viral disease.
As the heroin epidemic continues in New Jersey, an infectious disease specialist is finding that a growing number of heroin users are testing positive for a potentially deadly virus they don’t even know they had.
An experimental drug for one of the hardest-to-treat types of hepatitis C has been approved by the Food and Drug Administration, adding to the surge of new options -- all much more effective but extremely costly -- for patients with the liver-destroying virus.
WASHINGTON (AP) — The price may be high but so is demand. A new $1,000-per-pill drug has become the treatment of choice for Americans with hepatitis C, a liver-wasting disease that affects more than 3 million.
An experimental hepatitis C drug from Johnson & Johnson has won unanimous support from government advisers who say the medication should be approved to treat patients infected with the liver-destroying virus.
A traveling hospital technician accused of infecting dozens of patients with hepatitis C through tainted needles told investigators he had been stealing drugs for more than a decade and was "killing a lot of people," according to a plea agreement filed Monday that would send him to prison for 30 to 40 years.